A comparative study of Serum ALT levels in metabolic syndrome patients with and without NAFLD

Mamta Sagar; Sandeep Tripathi; Rajendra Dhar

doi:10.30574/ijsra.2023.10.2.0975

ISSN Approved Journal || eISSN: 2582-8185 || CODEN: IJSRO2 || Impact Factor 8.2 || Google Scholar and CrossRef Indexed

Peer Reviewed and Referred Journal || Free Certificate of Publication

Research and review articles are invited for publication in March 2026 (Volume 18, Issue 3) Submit manuscript

A comparative study of Serum ALT levels in metabolic syndrome patients with and without NAFLD

Mamta Sagar ¹, Sandeep Tripathi ^{1, *} and Rajendra Dhar ²

1 Department of Biochemistry, National Institute of Medical Sciences & Research, Nims University, Jaipur, Rajasthan, India.
2 Department of Medicine, National Institute of Medical Sciences & Research, Nims University, Jaipur, Rajasthan, India.

Research Article

International Journal of Science and Research Archive, 2023, 10(02), 490–496.

Article DOI: 10.30574/ijsra.2023.10.2.0975

DOI url: https://doi.org/10.30574/ijsra.2023.10.2.0975

Publication history

Received on 13 October 2023; revised on 26 November 2023; accepted on 29 November 2023

Abstract

Background: This study was undertaken to evaluate the Serum ALT levels in Metabolic Syndrome (MetS) patients with and without NAFLD. The objective was to compare the change in serum ALT levels in those patients.
Methods: The study was conducted in the Department of Biochemistry in association with Department of Medicine, National Institute of Medical Sciences and Hospital, Jaipur. At the same time adult diagnosed 150 MetS patients (75 without NAFLD & 75 with NAFLD) were taken. Anthropometric measurements were taken. ALT was measured in serum in both groups. The data obtained was statistically analyzed.
Results: Serum ALT was 67.89 ± 36.26 U/l in MetS with NAFLD while it was 46.03 ± 8.99U/l in without NAFLD.
Conclusions: increased ALT level is highly significant (p value < 0.001) in MetS with NAFLD as compare to without NAFLD. So increase in ALT in blood is associated with NAFLD in MetS patients.

Keywords

Metabolic Syndrome; NAFLD; SGPT; ALT

Download Article PDF

https://ijsra.net/sites/default/files/fulltext_pdf/IJSRA-2023-0975.pdf

Preview Article PDF

How to cite this article

Mamta Sagar, Sandeep Tripathi and Rajendra Dhar. A comparative study of Serum ALT levels in metabolic syndrome patients with and without NAFLD. International Journal of Science and Research Archive, 2023, 10(02), 490–496. Article DOI: https://doi.org/10.30574/ijsra.2023.10.2.0975

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.